Galera to present at jefferies healthcare conference

Malvern, pa., june 02, 2022 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will present at the 2022 jefferies healthcare conference on thursday, june 9, 2022 at 2:00 p.m. e.t.
GRTX Ratings Summary
GRTX Quant Ranking